MUSTACCHI, GIORGIO
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis
1997-01-01 C., Gridelli; Gp, Ianniello; G., Ambrosini; Mustacchi, Giorgio; T., Pedicini; A., Farris; S., Iacobelli; G., Rossi; G., Moretti; F., Angelini; M., DE LENA; A., DI CARLO; M., Bonsignori; R., Sabbatini; G., Catalano; A., Rossi; A., Olivieri; P., Fina; Ar, Bianco
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
2002-01-01 Mustacchi, Giorgio; M., Muggia; S., Milani; R., Ceccherini; ML LEITA AND C., Dellach
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.
2012-01-01 Gobbo, Margherita; Ottaviani, Giulia; Mustacchi, Giorgio; DI LENARDA, Roberto; Biasotto, Matteo
Adjuvant systemic treatment of early breast cancer: The NORA study.
2006-01-01 Cazzaniga, Me; Mustacchi, Giorgio; Pronzato, P.
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study
2007-01-01 M. E., Cazzaniga; Mustacchi, Giorgio; P., Pronzato; A., DE MATTEIS; F., DI COSTANZO; AND I., FLORIANI ON BEHALF OF THE NORA STUDY GROUP
Advances in systemic therapy for metastatic breast cancer: future perspectives
2017-01-01 Corona, S. P.; Sobhani, Navid; Ianza, Anna; Roviello, Giandomenico; Mustacchi, Giorgio; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
2006-01-01 Mustacchi, Giorgio; R., Ceccherini; C., Dellach; S., Foladore; S., Milani; M. LEITA AND M., Sisto
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study.
2007-01-01 Cazzaniga, Me; Mustacchi, Giorgio; Pronzato, P.
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study
2012-01-01 M., Clavarezza; Mustacchi, Giorgio; A., Casadei Gardini
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
2008-01-01 Ménard, S; Balsari, A; Tagliabue, E; Camerini, T; Casalini, P; Bufalino, R; Castiglioni, F; Carcangiu, Ml; Gloghini, A; Scalone, S; Querzoli, P; Lunardi, M; Molino, A; Mandarã, M; Mottolese, M; Marandino, F; Venturini, M; Bighin, C; Cancello, G; Montagna, E; Perrone, F; DE MATTEIS, A; Sapino, A; Donadio, M; Battelli, N; Santinelli, A; Pavesi, L; Lanza, A; Zito, Fa; Labriola, A; Aiello, Ra; Caruso, M; Zanconati, Fabrizio; Mustacchi, Giorgio; Barbareschi, M; Frisinghelli, M; Russo, R; Carrillo, G; Omero, Group
Breast cancer in elderly women: a different reality? Results from the NORA Study
2007-01-01 M. E., Cazzaniga; P., Pronzato; A., DE MATTEIS; F., DI COSTANZO; Mustacchi, Giorgio
Cancro del fegato: possibilità di diagnosi precoce
1992-01-01 Melato, Mauro; Zanconati, Fabrizio; Mustacchi, Giorgio
Carcinoma dell’ovaio
1998-01-01 Mustacchi, Giorgio; V., Amoroso; R., Ceccherini; M., Muggia
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study.
2011-01-01 Mustacchi, Giorgio; Me, Cazzaniga; P., Pronzato
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial.
1992-01-01 Boccardo, F.; Rubagotti, A.; Amoroso, D.; Sismondi, P.; Genta, F.; Nenci, I.; Piffanelli, A.; Farris, A.; Castagnetta, L.; Traina, A.; Cappellini, M.; Pacini, P.; Sassi, M.; Malacarne, P.; Donati, D.; Mustacchi, Giorgio; Galletto, L.; Schieppati, G.; Villa, E.; Bolognesi, A.; Gallo, L.
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial.
1993-01-01 Boccardo, F.; Rubagotti, A.; Amoroso, D.; Sismondi, P.; DE SANCTIS, C.; Farris, A.; Castagnetta, L.; Delia, P.; Traina, A.; Pacini, P.; Sassi, M.; Malacarne, P.; Donati, D.; Mustacchi, Giorgio; AND OTHERS PARTICIPANTS IN THE, Grocta
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study.
1997-01-01 F., Boccardo; D., Amoroso; S., Iacobelli; L., Irtelli; A., Farris; M., Mesiti; F., Brema; P., Pacini; E., Cortesi; P., Nardini; G., Guida; Mustacchi, Giorgio
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]]
2016-01-01 Arpino, Grazia; Generali, Daniele; Sapino, Anna; Del Mastro, Lucia; Frassoldati, Antonio; de Laurentiis, Michelino; Pronzato, Paolo; Mustacchi, Giorgio; Cazzaniga, Marina; De Placido, Sabino; Conte, Pierfranco; Cappelletti, Mariarosa; Zanoni, Vanessa; Antonelli, Andrea; Martinotti, Mario; Puglisi, Fabio; Berruti, Alfredo; Bottini, Alberto; Dogliotti, Luigi
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs
2017-01-01 Mustacchi, Giorgio; Generali, Daniele
Early detection of breast cancer recurrences through periodic follow up - Is it useless?
1985-01-01 S., Ciatto; Mustacchi, Giorgio; M., Simonis